1. Home
  2. HMN vs PVLA Comparison

HMN vs PVLA Comparison

Compare HMN & PVLA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Horace Mann Educators Corporation

HMN

Horace Mann Educators Corporation

N/A

Current Price

$51.20

Market Cap

2.1B

Sector

Finance

ML Signal

N/A

Logo Palvella Therapeutics Inc.

PVLA

Palvella Therapeutics Inc.

N/A

Current Price

$145.75

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
HMN
PVLA
Founded
1945
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.1B
2.0B
IPO Year
1996
2013

Fundamental Metrics

Financial Performance
Metric
HMN
PVLA
Price
$51.20
$145.75
Analyst Decision
Buy
Strong Buy
Analyst Count
3
15
Target Price
$47.33
$171.87
AVG Volume (30 Days)
225.3K
144.2K
Earning Date
05-06-2026
05-12-2026
Dividend Yield
3.05%
N/A
EPS Growth
57.26
52.62
EPS
2.01
N/A
Revenue
$1,701,400,000.00
$42,810,000.00
Revenue This Year
$6.91
N/A
Revenue Next Year
$3.41
$104,350.18
P/E Ratio
$25.17
N/A
Revenue Growth
6.66
65.28
52 Week Low
$41.29
$49.81
52 Week High
$55.56
$161.38

Technical Indicators

Market Signals
Indicator
HMN
PVLA
Relative Strength Index (RSI) 48.31 47.44
Support Level $50.60 $135.30
Resistance Level $53.34 $147.47
Average True Range (ATR) 1.39 7.20
MACD -0.22 -1.81
Stochastic Oscillator 25.13 34.58

Price Performance

Historical Comparison
HMN
PVLA

About HMN Horace Mann Educators Corporation

Horace Mann Educators Corp is a diversified insurance holding company that markets and underwrites personal lines of property and casualty insurance, retirement annuities, and life insurance. The company's property and casualty operations focus on automobile and homeowner insurance, while the retirement annuities are tax-qualified products. Horace Mann Educators markets its products to kindergarten through 12th-grade teachers, administrators, and other employees of public schools and their families. The Company conducts and manages its business in four reporting segments: (1) Property & Casualty, (2) Life & Retirement, (3) Supplemental & Group Benefits and (4) Corporate & Other.

About PVLA Palvella Therapeutics Inc.

Palvella Therapeutics Inc is a clinical-stage biopharmaceutical company whose vision is to become the rare disease biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no FDA-approved therapies. Its product candidate, QTORIN 3.9% rapamycin anhydrous gel, is currently in clinical development for microcystic lymphatic malformations and cutaneous venous malformations. It operates in single segment.

Share on Social Networks: